Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.55K Sell
97
-64
-40% -$5.19K ﹤0.01% 335
2025
Q4
$10.5K Buy
+161
New +$14.6K ﹤0.01% 237
2025
Q1
Sell
-201
Closed -$20.9K 502
2024
Q4
$20.9K Buy
201
+175
+673% +$16.6K ﹤0.01% 246
2024
Q3
$2.22K Buy
+26
New +$2.01K ﹤0.01% 321
2023
Q3
Sell
-1,540
Closed -$57.3K 518
2023
Q2
$57.3K Buy
1,540
+1,537
+51,233% +$61.5K 0.03% 160
2023
Q1
$118 Buy
+3
New +$118 ﹤0.01% 290
2022
Q4
Sell
-187
Closed -$8K 679
2022
Q3
$8K Sell
187
-124
-40% -$5K ﹤0.01% 287
2022
Q2
$13K Buy
311
+41
+15% +$1.52K ﹤0.01% 217
2022
Q1
$10K Buy
+270
New +$8.96K ﹤0.01% 161

Other funds holding LRN

Elequin Capital's LRN Position: Q1 2026 in Review

Elequin Capital reduced its Stride (LRN) stake by 40% in Q1 2026, selling an estimated $5.19K and leaving 97 shares worth $8.55K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Elequin Capital first reported a position in LRN in Q1 2022 and has held it in 9 quarters since. The position peaked at $57.3K in Q2 2023. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

  • Elequin Capital held 97 shares of Stride worth $8.55K as of Q1 2026.
  • Elequin Capital sold 64 Stride shares in Q1 2026, an estimated $5.19K.
  • Stride made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #335 holding.
  • Elequin Capital first reported a position in Stride in Q1 2022 and has held it in 9 quarters since.
  • Elequin Capital's Stride position peaked at $57.3K in Q2 2023.
  • 419 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.